Metastatic tumors in bone marrow: histopathology and advances in the biology of the tumor cells and bone marrow environment

Annals of Diagnostic Pathology

Volumn 10, Issue 3, 2006, Pages 169-192

  Cotta, Claudiu V ^a   Konoplev, Sergej ^a   Medeiros, L Jeffrey ^a   Bueso Ramos, Carlos E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bone marrow; Cytogenetics; Immunohistochemistry; Metastasis; Microenvironment; Molecular study

Indexed keywords

BONE MARROW BIOPSY; BONE MARROW EXAMINATION; BONE MARROW METASTASIS; BREAST CANCER; CANCER STAGING; CENTRAL NERVOUS SYSTEM TUMOR; CYTOGENETICS; DIAGNOSTIC ACCURACY; ENDOCRINE TUMOR; EWING SARCOMA; FEMALE GENITAL TRACT TUMOR; GASTROINTESTINAL CARCINOMA; GRANULAR CELL TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY TUMOR; LUNG CANCER; MEDULLOBLASTOMA; METASTASIS; MICROENVIRONMENT; MOLECULAR GENETICS; MORPHOLOGY; NEPHROBLASTOMA; NEUROBLASTOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SARCOMA; SKIN TUMOR; SMEAR; STAINING; TESTIS TUMOR; TUMOR CELL; UROGENITAL TRACT TUMOR;

BONE MARROW CELLS; BONE MARROW NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; TUMOR MARKERS, BIOLOGICAL;

EID: 33646813673     PISSN: 10929134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2006.04.001     Document Type: Review

References (149)

1. Anner R.M., and Drewinko B. Frequency and significance of bone marrow involvement by metastatic solid tumors. Cancer 39 (1977) 1337-1344
2. Miric A., Banks M., Allen D., et al. Cortical metastatic lesions of the appendicular skeleton from tumors of known primary origin. J Surg Oncol 67 (1998) 255-260
3. Johnston A.D. Pathology of metastatic tumors in bone. Clin Orthop Relat Res 73 (1970) 8-32
4. Coleman R.E. Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27 (2001) 165-176
5. Papac R.J. Bone marrow metastases. A review. Cancer 74 (1994) 2403-2413
6. Arkenau H.T., Mussig O., Buhr T., et al. Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature. Z Gastroenterol 43 (2005) 719-722
7. Burnell I., Tomkinson A., Hourihan M., et al. Mucin-secreting papillary adenocarcinoma of the hyoid bone: a unique case. J Laryngol Otol 119 (2005) 498-502
8. Millar A.J., Sinclair-Smith C., Mills A.E., et al. Mucin-secreting Wilms tumor. Report of two cases. Am J Pediatr Hematol Oncol 12 (1990) 201-204
9. Wong K.F., Chan J.K., and Ma S.K. Solid tumour with initial presentation in the bone marrow-a clinicopathologic study of 25 adult cases. Hematol Oncol 11 (1993) 35-42
10. Jardin F., Vasse M., Debled M., et al. Intense paraneoplastic neutrophilic leukemoid reaction related to a G-CSF-secreting lung sarcoma. Am J Hematol 80 (2005) 243-245
11. Nasr F., Corti C., Carde P., et al. Carcinoma cell leukemia. Blood 88 (1996) 2355-2357
12. Han X., and Bueso-Ramos C.E. Advances in the pathological diagnosis and biology of acute lymphoblastic leukemia. Ann Diagn Pathol 9 (2005) 239-257
13. Sandberg A.A., Stone J.F., Czarnecki L., et al. Hematologic masquerade of rhabdomyosarcoma. Am J Hematol 68 (2001) 51-57
14. Ali R., Ozkalemkas F., Ozcelik T., et al. Small cell lung cancer presenting as acute leukaemia. Cytopathology 16 (2005) 262-263
15. Braun S., and Naume B. Circulating and disseminated tumor cells. J Clin Oncol 23 (2005) 1623-1626
16. Mehes G., Witt A., Kubista E., et al. Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159 (2001) 17-20
17. Nosanchuk J., Terzian J., and Posso M. Circulating mucopolysaccharide (mucin) in two adults with metastatic adenocarcinoma. Detection in peripheral blood smear and at autopsy. Arch Pathol Lab Med 111 (1987) 545-548
18. Jatoi A., Dallal G.E., and Nguyen P.L. False-negative rates of tumor metastases in the histologic examination of bone marrow. Mod Pathol 12 (1999) 29-32
19. Barekman C.L., Fair K.P., and Cotelingam J.D. Comparative utility of diagnostic bone-marrow components: a 10-year study. Am J Hematol 56 (1997) 37-41
20. Moid F., and DePalma L. Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: institutional experience and literature review. Arch Pathol Lab Med 129 (2005) 497-501
21. Konoplev S., and Bueso-Ramos C.E. Advances in the pathologic diagnosis and biology of acute myeloid leukemia. Ann Diagn Pathol 10 (2006) 39-65
22. Burger J.A., and Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107 (2006) 1761-1767
23. Yoneda T., and Hiraga T. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 328 (2005) 679-687
24. Kucia M., Reca R., Miekus K., et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23 (2005) 879-894
25. Libura J., Drukala J., Majka M., et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. Blood 100 (2002) 2597-2606
26. Hart C.A., Brown M., Bagley S., et al. Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. Br J Cancer 92 (2005) 503-512
27. Bakewell S.J., Nestor P., Prasad S., et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc Natl Acad Sci U S A 100 (2003) 14205-14210
28. Sohara Y., Shimada H., and DeClerck Y.A. Mechanisms of bone invasion and metastasis in human neuroblastoma. Cancer Lett 228 (2005) 203-209
29. Thomas R.J., Guise T.A., Yin J.J., et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology 140 (1999) 4451-4458
30. Dimitroff C.J., Descheny L., Trujillo N., et al. Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Res 65 (2005) 5750-5760
31. Sipkins D.A., Wei X., Wu J.W., et al. In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment. Nature 435 (2005) 969-973
32. Hill A., McFarlane S., Johnston P.G., et al. The emerging role of CD44 in regulating skeletal micrometastasis. Cancer Lett (2005) [Epub ahead of print]
33. Kozlow W., and Guise T.A. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 10 (2005) 169-180
34. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
35. Goltzman D., Karaplis A.C., Kremer R., et al. Molecular basis of the spectrum of skeletal complications of neoplasia. Cancer 88 (2000) 2903-2908
36. Price J.T., Quinn J.M., Sims N.A., et al. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res 65 (2005) 4929-4938
37. Pantel K., and Woelfle U. Detection and molecular characterisation of disseminated tumour cells: implications for anti-cancer therapy. Biochim Biophys Acta 1756 (2005) 53-64
38. Hayes D.F. Prognostic and predictive factors revisited. Breast 14 (2005) 493-499
39. Muller V., Stahmann N., Riethdorf S., et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 11 (2005) 3678-3685
40. O'Connor O.J., Cahill R.A., Kirwan W.O., et al. The impact of bone marrow micrometastases on metastatic disease-free survival in patients with colorectal carcinoma. Colorectal Dis 7 (2005) 406-409
41. Wiedswang G., Borgen E., Karesen R., et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol 21 (2003) 3469-3478
42. Muller V., and Pantel K. Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives. Breast Cancer Res 6 (2004) 258-261
43. Ihde D.C., Simms E.B., Matthews M.J., et al. Bone marrow metastases in small cell carcinoma of the lung: frequency, description, and influence on chemotherapeutic toxicity and prognosis. Blood 53 (1979) 677-686
44. Clamon G.H., Edwards W.R., Hamous J.E., et al. Patterns of bone marrow involvement with small cell lung cancer. Cancer 54 (1984) 100-102
45. Schlette E., Medeiros L.J., Beran M., et al. Indolent neuroendocrine tumor involving the bone marrow. A case report with a 9-year follow-up. Arch Pathol Lab Med 127 (2003) 488-491
46. Muggia F.M., and Hansen H.H. Osteoblastic metastases in small-cell (oat-cell) carcinoma of the lung. Cancer 30 (1972) 801-805
47. Iguchi T., Awaya N., Kobayashi K., et al. Bone marrow metastasis of small cell carcinoma of the lung mimicking Burkitt lymphoma/leukaemia. Br J Haematol 130 (2005) 652
48. Hansen H.H., Muggia F.M., and Selawry O.S. Bone-marrow examination in 100 consecutive patients with bronchogenic carcinoma. Lancet 2 (1971) 443-445
49. Ridell B., and Landys K. Incidence and histopathology of metastases of mammary carcinoma in biopsies from the posterior iliac crest. Cancer 44 (1979) 1782-1788
50. Ingle J.N., Tormey D.C., and Tan H.K. The bone marrow examination in breast cancer: diagnostic considerations and clinical usefulness. Cancer 41 (1978) 670-674
51. Landys K. Prognostic value of bone marrow biopsy in breast cancer. Cancer 49 (1982) 513-518
52. DiStefano A., Tashima C.K., Yap H.Y., et al. Bone marrow metastases without cortical bone involvement in breast cancer patients. Cancer 44 (1979) 196-198
53. Coleman R.E., Smith P., and Rubens R.D. Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 77 (1998) 336-340
54. Borst M.J., and Ingold J.A. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery 114 (1993) 637-641 [discussion 41-2]
55. Ferlicot S., Vincent-Salomon A., Medioni J., et al. Wide metastatic spreading in infiltrating lobular carcinoma of the breast. Eur J Cancer 40 (2004) 336-341
56. Jain S., Fisher C., Smith P., et al. Patterns of metastatic breast cancer in relation to histological type. Eur J Cancer 29A (1993) 2155-2157
57. Ninomiya J., Oyama T., Horiguchi J., et al. Two cases of breast cancer with cartilaginous and osseous metaplasia. Breast Cancer 12 (2005) 52-56
58. El Omari-Alaoui H., Lahdiri I., Nejjar I., et al. Male breast cancer. A report of 71 cases. Cancer Radiother 6 (2002) 349-351
59. Deeming G., Divakaran R., Butterworth D., et al. Temporomandibular region metastasis from cystosarcoma phyllodes: a case report and review of the literature. J Craniomaxillofac Surg 31 (2003) 325-328
60. Cote R.J., Rosen P.P., Lesser M.L., et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9 (1991) 1749-1756
61. Lehr J.E., and Pienta K.J. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst 90 (1998) 118-123
62. Schneider A., Kalikin L.M., Mattos A.C., et al. Bone turnover mediates preferential localization of prostate cancer in the skeleton. Endocrinology 146 (2005) 1727-1736
63. Roudier M.P., True L.D., Higano C.S., et al. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol 34 (2003) 646-653
64. Lim K.H., Huang M.J., Yang S., et al. Primary carcinoid tumor of prostate presenting with bone marrow metastases. Urology 65 (2005) 174
65. Jonas S., Weinrich M., Tullius S.G., et al. Microscopic tumor cell dissemination in gastric cancer. Surg Today 34 (2004) 101-106
66. Chung Y.S., Choi T.Y., Ha C.Y., et al. An unusual case of osteoblastic metastasis from gastric carcinoma. Yonsei Med J 43 (2002) 377-380
67. Kobayashi M., Okabayashi T., Sano T., et al. Metastatic bone cancer as a recurrence of early gastric cancer-characteristics and possible mechanisms. World J Gastroenterol 11 (2005) 5587-5591
68. Plockinger U., and Wiedenmann B. Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours. Best Pract Res Clin Gastroenterol 19 (2005) 553-576
69. Kaya G., Pasche C., Osterheld M.C., et al. Primary neuroendocrine carcinoma of the liver: an autopsy case. Pathol Int 51 (2001) 874-878
70. Ohike N., and Morohoshi T. Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis. Endocr Pathol 16 (2005) 33-40
71. Casas F., Ferrer F., Farrus B., et al. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer 80 (1997) 1366-1372
72. Wu Z., Ma J.Y., Yang J.J., et al. Primary small cell carcinoma of esophagus: report of 9 cases and review of literature. World J Gastroenterol 10 (2004) 3680-3682
73. Jaehne M., Roeser K., Jaekel T., et al. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases. Cancer 103 (2005) 2526-2533
74. Terhaard C.H., Lubsen H., Van der Tweel I., et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 26 (2004) 681-692 [discussion 92-3]
75. Wenig B.M., Hitchcock C.L., Ellis G.L., et al. Metastasizing mixed tumor of salivary glands. A clinicopathologic and flow cytometric analysis. Am J Surg Pathol 16 (1992) 845-858
76. Fu K.K., Leibel S.A., Levine M.L., et al. Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer 40 (1977) 2882-2890
77. Lima R.A., Tavares M.R., Dias F.L., et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg 133 (2005) 702-708
78. Sutcliffe R., Maguire D., Murphy P., et al. Detection and clinical significance of bone marrow micrometastases in patients undergoing liver transplantation for hepatocellular carcinoma. Transplantation 80 (2005) 88-94
79. Lee Y.T. Leiomyosarcoma of the gastro-intestinal tract: general pattern of metastasis and recurrence. Cancer Treat Rev 10 (1983) 91-101
80. Nabeshima S., Kishihara Y., Nabeshima A., et al. Poorly differentiated adenocarcinoma with signet-ring cells of the Vater's ampulla, without jaundice but with disseminated carcinomatosis. Fukuoka Igaku Zasshi 94 (2003) 235-240
81. Flanigan R.C., Campbell S.C., Clark J.I., et al. Metastatic renal cell carcinoma. Curr Treat Options Oncol 4 (2003) 385-390
82. Kuczyk M.A., Anastasiadis A.G., Zimmermann R., et al. Current aspects of the surgical management of organ-confined, metastatic, and recurrent renal cell cancer. BJU Int 96 (2005) 721-727 [quiz i-ii]
83. De Vos C., Gerard J.M., Decat M., et al. Metastatic renal cell carcinoma to the temporal bone: case report. B-ENT 1 (2005) 43-46
84. Tongaonkar H.B., Kulkarni J.N., and Kamat M.R. Solitary metastases from renal cell carcinoma: a review. J Surg Oncol 49 (1992) 45-48
85. Altinoz M.A., Santaguida C., Guiot M.C., et al. Spinal hemangioblastoma containing metastatic renal cell carcinoma in von Hippel-Lindau disease. Case report and review of the literature. J Neurosurg Spine 3 (2005) 495-500
86. Medeiros L.J., Wolf B.C., Balogh K., et al. Adrenal pheochromocytoma: a clinicpathologic review of 60 cases. Human Pathol 16 (1985) 580-589
87. Cohn-Cedermark G., Mansson-Brahme E., Rutqvist L.E., et al. Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncol 38 (1999) 549-557
88. Spiller S.E., Hawkins D.S., Finn L.S., et al. Metastatic malignant melanoma presenting as pancytopenia in a three-year-old boy. Pediatr Blood Cancer 45 (2005) 60-63
89. Baloch Z.W., Sack M.J., Yu G.H., et al. Papillary formations in metastatic melanoma. Diagn Cytopathol 20 (1999) 148-151
90. Saikia B., Varma N., Mohan C., et al. Metastatic bone marrow involvement by squamous cell carcinoma of the tonsil. J Otolaryngol 31 (2002) 184-186
91. Ting P.T., Kasper R., and Arlette J.P. Metastatic basal cell carcinoma: report of two cases and literature review. J Cutan Med Surg 9 (2005) 10-15
92. Knoeller S.M., Haag M., Adler C.P., et al. Skeletal metastasis in tricholemmal carcinoma. Clin Orthop Relat Res (2004) 213-216
93. Meyer T.K., Rhee J.S., Smith M.M., et al. External auditory canal eccrine spiradenocarcinoma: a case report and review of literature. Head Neck 25 (2003) 505-510
94. Kamijo A., Koshino T., Hirakawa K., et al. Merkel cell carcinoma with bone metastasis: a case report. J Orthop Sci 7 (2002) 574-577
95. Clark J.R., Lai P., Hall F., et al. Variables predicting distant metastases in thyroid cancer. Laryngoscope 115 (2005) 661-667
96. Kumar P.V., Monabati A., Tabei S.Z., et al. Metastatic follicular thyroid carcinoma diagnosed by fine needle aspiration cytology: a report of 3 cases. Acta Cytol 49 (2005) 177-180
97. Weber T., Lacroix J., Worner S., et al. Detection of hematogenic and lymphogenic tumor cell dissemination in patients with medullary thyroid carcinoma by cytokeratin 20 and preprogastrin-releasing peptide RT-PCR. Int J Cancer 103 (2003) 126-131
98. Favia G., Lumachi F., Polistina F., et al. Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg 22 (1998) 1225-1230
99. George J., and Lai F.M. Metastatic cervical carcinoma presenting as psoas abscess and osteoblastic and lytic bony metastases. Singapore Med J 36 (1995) 224-227
100. Ratanatharathorn V., Powers W.E., Steverson N., et al. Bone metastasis from cervical cancer. Cancer 73 (1994) 2372-2379
101. Uharcek P., Mlyncek M., and Ravinger J. Endometrial adenocarcinoma presenting with an osseous metastasis. Gynecol Obstet Invest 61 (2006) 200-202
102. Punyavoravut V., and Nelson S.D. Diffuse bony metastasis from transitional cell carcinoma of urinary bladder: a case report and review of literature. J Med Assoc Thai 82 (1999) 839-843
103. Sengelov L., Kamby C., and von der Maase H. Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. J Urol 155 (1996) 111-114
104. Sengelov L., von der Maase H., Kamby C., et al. Assessment of patients with metastatic transitional cell carcinoma of the urinary tract. J Urol 162 (1999) 343-346
105. Matthews P.N., Madden M., Bidgood K.A., et al. The clinicopathological features of metastatic superficial papillary bladder cancer. J Urol 132 (1984) 904-906
106. Evison G., Pizey N., and Roylance J. Bone formation associated with osseous metastases from bladder carcinoma. Clin Radiol 32 (1981) 303-309
107. Petkovic M., Muhvic D., Zamolo G., et al. Metatarsal metastasis from transitional cell cancer of the urinary bladder. Coll Antropol 28 (2004) 337-341
108. Liel Y., Maor E., Ariad S., et al. Severe, diffuse osteosclerosis: a new manifestation of transitional cell carcinoma of the urinary bladder. Calcif Tissue Int 63 (1998) 471-474
109. Shimizu K., and Imaida K. Metastatic transitional cell carcinoma or nonsecretory multiple myeloma?. Clin Lab Haematol 23 (2001) 67
110. Calaminus G., Schneider D.T., Bokkerink J.P., et al. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89. J Clin Oncol 21 (2003) 781-786
111. Johnson D.E., Appelt G., Samuels M.L., et al. Metastases from testicular carcinoma. Study of 78 autopsied cases. Urology 8 (1976) 234-239
112. Hermann G., Novick A., and Carr L. Skeletal metastases of seminoma of the testicle. Mt Sinai J Med 53 (1986) 294-296
113. Merrick M.V. Bone scintigraphy in testicular tumours. Br J Urol 60 (1987) 167-169
114. Korfel A., Fischer L., Foss H.D., et al. Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature. Bone Marrow Transplant 28 (2001) 787-789
115. Uygun K., Karagol H., Kocak Z., et al. Isolated bone metastasis in testicular germ cell tumors: a case report and review of the literature. Onkologie 29 (2006) 93-95
116. Wenger D.E., Wold L.E., et al. Malignant vascular lesions of bone: radiologic and pathologic features. Skeletal Radiol 29 (2000) 619-631
117. Miura K., Hatori M., Hosaka M., et al. Primary leiomyosarcoma with the invasion into the intertrabecular space of bone: a case report and the review of the literatures. Clin Imaging 25 (2001) 209-214
118. Ricchetti T., Paci M., Cavazza A., et al. A case of metastatic epithelioid angiosarcoma in the lamina propria of a sigmoid tubulovillous adenoma. Tumori 91 (2005) 210-212
119. Fury M.G., Antonescu C.R., Van Zee K.J., et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 11 (2005) 241-247
120. Wang C., Rabah R., Blackstein M., et al. Bone marrow metastasis of angiosarcoma. Pathol Res Pract 200 (2004) 551-555
121. Yilmazlar T., Kirdak T., Adim S., et al. A case of hemangiosarcoma in thyroid with severe anemia due to bone marrow metastasis. Endocr J 52 (2005) 57-59
122. Bruland O.S., Hoifodt H., Saeter G., et al. Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res 11 (2005) 4666-4673
123. Wang L.L. Biology of osteogenic sarcoma. Cancer J 11 (2005) 294-305
124. Kawano T., Hamada J., Morioka M., et al. Skull metastasis from clear cell chondrosarcoma. Neurol Med Chir (Tokyo) 45 (2005) 367-370
125. Bramwell V.H., Littley M.B., Chang J., et al. Bone marrow involvement in adult soft tissue sarcomas. Eur J Cancer Clin Oncol 18 (1982) 1099-1106
126. Enam S.A., Abdulrauf S., Mehta B., et al. Metastasis in meningioma. Acta Neurochir (Wien) 138 (1996) 1172-1177 [discussion 7-8]
127. Rajagopalan V., Kamar F.G., Thayaparan R., et al. Bone marrow metastases from glioblastoma multiforme-a case report and review of the literature. J Neurooncol 72 (2005) 157-161
128. Giordana M.T., Ghimenti C., Leonardo E., et al. Molecular genetic study of a metastatic oligodendroglioma. J Neurooncol 66 (2004) 265-271
129. Al-Ali F., Hendon A.J., Liepman M.K., et al. Oligodendroglioma metastatic to bone marrow. AJNR Am J Neuroradiol 26 (2005) 2410-2414
130. Anand M., Kumar R., Jain P., et al. Metastatic anaplastic oligodendroglioma simulating acute leukemia. A case report. Acta Cytol 47 (2003) 467-469
131. Farrier S.E., Agosti S., Morgan M., et al. Metastatic ependymoma manifested by pancytopenia. South Med J 87 (1994) 1262-1263
132. Constantine C., Miller D.C., Gardner S., et al. Osseous metastasis of pineoblastoma: a case report and review of the literature. J Neurooncol 74 (2005) 53-57
133. Shimada H., Ambros I.M., Dehner L.P., et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 86 (1999) 364-372
134. Mills A.E., and Bird A.R. Bone marrow changes in neuroblastoma. Pediatr Pathol 5 (1986) 225-234
135. Reid M.M., and Hamilton P.J. Histology of neuroblastoma involving bone marrow: the problem of detecting residual tumour after initiation of chemotherapy. Br J Haematol 69 (1988) 487-490
136. Lonergan G.J., Schwab C.M., Suarez E.S., et al. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 22 (2002) 911-934
137. Russell H.V., Golding L.A., Suell M.N., et al. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma. Pediatr Blood Cancer 45 (2005) 916-919
138. Escobar M.A., Grosfeld J.L., Powell R.L., et al. Long-term outcomes in patients with stage IV neuroblastoma. J Pediatr Surg 41 (2006) 377-381
139. Raney R.B., Anderson J.R., Barr F.G., et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23 (2001) 215-220
140. Carli M., Colombatti R., Oberlin O., et al. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol 22 (2004) 4787-4794
141. Miyoshi I., Uemura Y., Muneishi H., et al. Bone marrow metastasis of alveolar rhabdomyosarcoma. Intern Med 44 (2005) 677-678
142. Chen L., Shah H.O., and Lin J.H. Alveolar rhabdomyosarcoma with concurrent metastases to bone marrow and lymph nodes simulating acute hematologic malignancy. J Pediatr Hematol Oncol 26 (2004) 696-697
143. Rickert C.H. Extraneural metastases of paediatric brain tumours. Acta Neuropathol (Berl) 105 (2003) 309-327
144. Eberhart C.G., Cohen K.J., Tihan T., et al. Medulloblastomas with systemic metastases: evaluation of tumor histopathology and clinical behavior in 23 patients. J Pediatr Hematol Oncol 25 (2003) 198-203
145. Kunschner L.J., Kuttesch J., Hess K., et al. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro-oncol 3 (2001) 167-173
146. Koscielniak E., Morgan M., and Treuner J. Soft tissue sarcoma in children: prognosis and management. Paediatr Drugs 4 (2002) 21-28
147. Folpe A.L., Goldblum J.R., Rubin B.P., et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol 29 (2005) 1025-1033
148. Lazda E.J., and Berry P.J. Bone marrow metastasis in Ewing's sarcoma and peripheral primitive neuroectodermal tumor: an immunohistochemical study. Pediatr Dev Pathol 1 (1998) 125-130
149. Bernstein M.L., Devidas M., Lafreniere D., et al. Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457-a report from the Children's Oncology Group. J Clin Oncol 24 (2006) 152-159